ACHE and Alzheimer disease: Among the four medications currently approved by the US FDA (Food and Drug Administration) for treating the cognitive deficiency of AD, three are acetylcholinesterase inhibitors (donepezil, galantamine and rivastigmine), which increase cholinergic activity.